WuXi AppTec Unveils Manufacturing Center for Cutting Edge Cell and Gene Therapies

SourcePR Newswire
Date Published10/06/2016
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name WuXi AppTec
Type of work Manufacturing
If manufacturing, is the company an OEM? Yes
Reshoring category:Transplant
Total number of jobs (added or to be added):200
Year reshoring announced:2016
Domestically, the work will be done:In-house
Country(ies) from which reshored:China
City reshored to:Philadelphia
State(s) reshored to:PA
If relevant, work nearshored to:-
Product(s) reshoredCell Therapy Products
What domestic positive factors made reshoring more attractive?Customer responsiveness improvement, Manufacturing/engineering joint innovation (R&D)
Find Reshoring Articles